Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum.
about
Neuroimmune interaction in inflammatory diseasesNeurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.Cryptosporidium and host resistance: historical perspective and some novel approaches.Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.Neuropeptide substance P and the immune response.
P2860
Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@ast
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@en
type
label
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@ast
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@en
prefLabel
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@ast
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@en
P2093
P2860
P1476
Treatment with neurokinin-1 re ...... ced by Cryptosporidium parvum.
@en
P2093
Dhuha Akili
Ioana M Sonea
James A Harp
Mitchell V Palmer
P2860
P304
P356
10.1128/CDLI.9.2.333-340.2002
P577
2002-03-01T00:00:00Z